ScienceMed®

Avaliação de uma mistura probiótica em saúde psicossocial e biomarcadores de resposta inflamatória, imunológica e de estresse em adultos com depressão sublimiar: um ensaio duplo-cego, randomizado, controlado com placebo

Endocrinologia
Imagem de arquivo, ilustrativa — não é do estudo. Tratografia por ressonância magnética: tratos de substância branca no cérebro de um camundongo. NIH · domínio público · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaThe British journal of nutrition29 out 202413 citações

Salvar

O que aconteceu

This study examined the efficacy of a probiotic in reducing depressive symptom severity in people with subthreshold depression. In a double-blind, randomised, placebo-controlled trial, a probiotic (1 × 10^9 live cells per strain: Limosilactobacillus fermentum LF16 (DSM26956), Lacticaseibacillus rhamnosus LR06 (DSM21981), Lactiplantibacillus plantarum LP01 (LMG P-21021) and Bifidobacterium longum 04 (DSM23233)) or placebo was taken daily for 12 weeks. Data were collected at baseline, 6 and 12 weeks including psychological symptom severity (Beck Depression Inventory, BDI; Patient Health Questionnaire, PHQ; Hospital Anxiety Depression Scale, HADS; and Depression Anxiety and Stress Scale, DASS). Biomarkers of glycaemia, inflammation (high-sensitivity C-reactive protein, hs-CRP), antioxidant status (total glutathione (GSH)) and stress (cortisol awakening response, CAR) were also measured. Thirty-nine participants (nineteen probiotic; twenty placebo) were enrolled. There were no significant between-group differences in the examined psychological symptom severity scores, despite certain significant within-group changes observed in both groups from baseline to 6 and/or 12 weeks of follow-up. Regarding biomarkers, the probiotic group showed reduced hs-CRP (-1520; 95 % CI -273·7, -2766·2 ng/dl) and CAR (-0·28; 95 % CI -0·05, -0·51 μg/dl) at 12 weeks, but increased total GSH (3·9; 95 % CI 0·1, 7·5 ng/dl) at 6 weeks, compared with the placebo. The current study reported favourable decreases in depressive symptoms in both groups. Although the within-group changes observed in the probiotic group were supported by favourable inflammatory, antioxidant status and stress biomarker changes compared with the placebo, further research is required to shed more light on the role of gut microbiota modulation on emotional regulation.

Trecho mantido em inglês: a tradução automática não passou na conferência de números.

Tradução automática do resumo original, publicado em The British journal of nutrition sob licença CC BY. Os números são conferidos contra o original; siglas e termos técnicos podem variar.

O estudo original

Evaluation of a probiotic blend on psychosocial health and biomarkers of inflammatory, immune and stress response in adults with subthreshold depression: a double-blind, randomised, placebo-controlled trial

George Moschonis, Katerina Sarapis, Stephanie Resciniti, Renate Hall, Kanny Yim, Matilda Tonkovic, Clare Fitzgerald, Fay Anixiadis, Antony Vinh, Quynh Nhu Dinh et al.

Descritores MeSH

  • Depression
  • Probiotics
  • Stress, Psychological
  • Double-Blind Method
  • Female
  • Humans
  • Hydrocortisone
  • Inflammation
  • Male
  • Middle Aged

Veja também